Hypersensory Bladder Disease: Concept and Pathogenetic Basis
- 作者: Kuzmin I.V.1, Slesarevskaya M.N.1
-
隶属关系:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- 期: 卷 15, 编号 2 (2025)
- 页面: 173-181
- 栏目: Reviews
- URL: https://bakhtiniada.ru/uroved/article/view/314198
- DOI: https://doi.org/10.17816/uroved686232
- EDN: https://elibrary.ru/YRUCGQ
- ID: 314198
如何引用文章
详细
This review article is devoted to current concepts of hypersensory bladder. It provides a detailed description of the epidemiological, clinical, and pathophysiological features of overactive bladder and bladder pain syndrome / interstitial cystitis, emphasizing the similarity of their clinical manifestations. The molecular mechanisms of the mechanosensory function of the urothelium under normal conditions and in the presence of hypersensory disorders are thoroughly described. The data presented allow these conditions to be regarded as manifestations of a common pathological process based on increased bladder sensitivity. It is noted that the mechanism of hypersensitivity in overactive bladder and bladder pain syndrome / interstitial cystitis is similar and involves the pathological amplification of afferent signal transmission from the bladder to the central nervous system. This process may be associated with multiple factors, but inflammation is regarded as the main cause of increased afferent activity in the bladder. The role of central sensitization in the development of hypersensory bladder disorders is also highlighted. Given the commonality in symptoms, clinical course, and pathogenesis, the concept of “hypersensory bladder disease” is proposed, uniting the hypersensory phenotypes of overactive bladder and bladder pain syndrome / interstitial cystitis. It is stated that this concept is justified from a pathogenetic standpoint, although many aspects require further investigation and discussion.
作者简介
Igor Kuzmin
Academician I.P. Pavlov First St. Petersburg State Medical University
编辑信件的主要联系方式.
Email: kuzminigor@mail.ru
ORCID iD: 0000-0002-7724-7832
SPIN 代码: 2684-4070
MD, Dr. Sci. (Medicine), Professor
俄罗斯联邦, Saint PetersburgMargarita Slesarevskaya
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: mns-1971@yandex.ru
ORCID iD: 0000-0002-4911-6018
SPIN 代码: 9602-7775
MD, Cand. Sci. (Medicine)
俄罗斯联邦, Saint Petersburg参考
- Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760–766. doi: 10.1046/j.1464-410X.2001.02228.x EDN: BACBIR
- Slesarevskaya MN, Ignashov YuA, Kuzmin IV, Al-Shukri SK. Persistent dysuria in women: etiological diagnostics and treatment. Urology reports (St. Petersburg). 2021;11(3):195–204. doi: 10.17816/uroved81948 EDN: BDUFWQ
- Zaytsev AV, Sharov MN, Ibragimov RA, et al. Painful bladder syndrome / interstitial cystitis: modern approaches to diagnosis and treatment. Ambulance Doctor. 2018;(8):16–26. EDN: YLJJWX
- Peyronnet B, Mironska E, Chapple C, et al. A Comprehensive review of overactive bladder pathophysiology: On the way to tailored treatment. Eur Urol. 2019;75(6):988–1000. doi: 10.1016/j.eururo.2019.02.038
- Abrams P, Cardozo L, Fall M, et al. The standartisation of terminology in lower urinary tract function: Report from the standartisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–178. doi: 10.1002/nau.10052
- Kuzmin IV. Pathogenesis, clinical course and treatment of overactive bladder [dissertation]. Saint Petersburg; 2007. EDN: QECRJB (In Russ.)
- Van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–67. doi: 10.1016/j.eururo.2007.09.019
- Hanno PM, Erickson D, Moldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–1553. doi: 10.1016/j.juro.2015.01.086
- Engeler D, Baranowski AP, Berghmans B, et al. EAU guidelines on chronic pelvic pain. European Association of Urology; 2025.
- Niimi A, Akiyama Y, Tomonori Y, et al. Clinical manifestations of interstitial cystitis and bladder pain syndrome: Analysis of a patient registry in Japan. Int J Urol. 2025;32(1):103–109. doi: 10.1111/iju.15603 EDN: JOTNUC
- Kuzmin IV. Epidemiological aspects of overactive bladder and urge urinary incontinence. Urology reports (St. Petersburg). 2015;5(3):30–34. doi: 10.17816/uroved5330-3 EDN: VHUCCH
- Kuzmin IV, Slesarevskaya MN, Saveliev MV. Bladder pain syndrome. Terminological and epidemiological aspects. Experimental and Clinical Urology. 2025;18(1):175–184. doi: 10.29188/2222-8543-2025-18-1-175-184 EDN: HGNIPW
- Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–544. doi: 10.1016/j.juro.2011.03.132
- Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975;64(2):75–77.
- Clemens JQ, Meenan RT, Rosetti MC, et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173(1):98–102. doi: 10.1097/01.ju.0000146114.53828.82
- Developed by the Joint Writing Group of the International Urogynecological Association and the American Urogynecologic Society. Joint terminology report: Terminology standardization for female bladder pain syndrome. Int Urogynecol J. 2025;36(2):265–277. doi: 10.1007/s00192-024-05923-z
- Elliott CS, Payne CK. Interstitial cystitis and the overlap with overactive bladder. Curr Urol Rep. 2012;13(5):319–326. doi: 10.1007/s11934-012-0264-y EDN: PGMWEN
- Castro-Diaz D, Cardozo L, Chapple CR, et al. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences? Int J Clin Pract. 2014;68(3):356–362. doi: 10.1111/ijcp.12317
- Clemens JQ, Bogart LM, Liu K, et al. Perceptions of “urgency” in women with interstitial cystitis / bladder pain syndrome or overactive bladder. Neurourol Urodyn. 2011;30(3):402–405. doi: 10.1002/nau.20974
- Lai HH, Vetter J, Jain S, et al. The overlap and distinction of self-reported symptoms between interstitial cystitis / bladder pain syndrome and overactive bladder: A questionnaire-based analysis. J Urol. 2014;192(6):1679–1685. doi: 10.1016/j.juro.2014.05.102
- Kuzmin IV. Assessment of the quality of life in patients with overactive bladder. Nephrology (Saint-Petersburg). 2006;10(4):93–97. EDN: JURDFP
- Slesarevskaya MN, Kuzmin IV, Ignashov YA. Characteristics of symptoms and psychosomatic status in women with chronic pelvic pain syndrome. Urology reports (St. Petersburg). 2015;5(3):16–19. doi: 10.17816/uroved5316-19 EDN: VHUCAT
- Driscoll A, Teichman JM. How do patients with interstitial cystitis present? J Urol. 2001;166(6):2118–2120. doi: 10.1016/S0022-5347(05)65517-6
- Warren JW, Wesselmann U, Greenberg P, Clauw DJ. Urinary symptoms as a prodrome of bladder pain syndrome / interstitial cystitis. Urology. 2014;83(5):1035–1040. doi: 10.1016/j.urology.2014.01.012
- Wennberg A-L, Molander U, Fall M, et al. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol. 2009;55(4):783–791. doi: 10.1016/j.eururo.2009.01.00
- Phé V, Gamé X. Definition, epidemiology and impact of non-neurogenic overactive bladder. Prog Urol. 2020;30(14):866–872. doi: 10.1016/j.purol.2020.09.002 EDN: ENTZMA
- Held PJ, Hanno PM, Wein AJ, et al. Epidemiology of interstitial cystitis: 2. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ, editors. Interstitial cystitis. London: Springer-Verlag; 1990. P. 29–48. doi: 10.1007/978-1-4471-3293-6_4
- Thurmond P, Yang J-H, Azadzoi KM. LUTS in pelvic ischemia: a new concept in voiding dysfunction. Am J Physiol Renal Physiol. 2016;310(8):F738–F743. doi: 10.1152/ajprenal.00333.201521
- Al-Shukri SH, Kuzmin IV, Boriskin AG, et al. Correction of microcirculatory disorders in patients with overactive bladder. Nephrology (Saint-Petersburg). 2011;15(1):58–64. EDN: NUDVJN
- Pinggera G-M, Mitterberger M, Steiner E, et al. Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography. BJU Int. 2008;102(4):470–474. doi: 10.1111/j.1464-410X.2008.07587.x
- Sekido N, Hinotsu S, Kawai K, et al. How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study? Int J Urol. 2006;13(10):1276–1279. doi: 10.1111/j.1442-2042.2006.01558.x
- Fry CH, McCloskey KD. Spontaneous Activity and the Urinary Bladder. Adv Exp Med Biol. 2019;1124:121–147. doi: 10.1007/978-981-13-5895-1_5
- Kushida N, Fry CH. On the origin of spontaneous activity in the bladder. BJU Int. 2016;117(6):982–992. doi: 10.1111/bju.13240
- Birder LA, de Groat WC. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol. 2007;4(1):46–54. doi: 10.1038/ncpuro0672
- Yoshimura N, Ogawa T, Miyazato M, et al. Neural mechanisms underlying lower urinary tract dysfunction. Korean J Urol. 2014;55(2):81–90. doi: 10.4111/kju.2014.55.2.81
- Kuzmin IV, Slesarevskaya MN, Romikh VV. Overactive bladder, inflammation and urinary tract infection: pathogenetic parallels. Urology reports (St. Petersburg). 2024;14(1):65–79. doi: 10.17816/uroved627461 EDN: GAHDJA
- Chen L, Xu X, Zhou Y. The association between the systemic inflammation response index and overactive bladder: a cross-sectional study. Eur J Med Res. 2025;30(1):481. doi: 10.1186/s40001-025-02773-3
- Jiang Y-H, Jhang J-F, Hsu Y-H, Kuo H-C. Usefulness of urinary biomarkers for assessing bladder condition and histopathology in patients with interstitial cystitis/bladder pain syndrome. Int J Mol Sci. 2022;23(19):12044. doi: 10.3390/ijms231912044 EDN: DIRZMH
- Zwaans BMM, Mota S, Bartolone SN, et al. Evaluating symptom severity and urinary cytokine levels in interstitial cystitis/bladder pain syndrome patients, with and without Hunner’s lesions. Am J Clin Exp Urol. 2024;12(2):110–118. doi: 10.62347/BLED240
- Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73(1):52–57. doi: 10.1016/j.urology.2008.06.031
- Vanneste M, Segal A, Voets T, Everaerts W. Transient receptor potential channels in sensory mechanisms of the lower urinary tract. Nat Rev Urol. 2021;18(3):139–159. doi: 10.1038/s41585-021-00428-6 EDN: RLNJQR
- Li Z, Lin D, Luo C, et al. The expression and function of piezo channels in bladder. Bladder (San Franc). 2023;10:e21200008. doi: 10.14440/bladder.2023.870 EDN: EPKJIY
- Frazer MI, Haylen BT, Sissons M. Do women with idiopathic sensory urgency have early interstitial cystitis? Br J Urol. 1990;66(3):274–278. doi: 10.1111/j.1464-410x.1990.tb14925.x
- Yamaguchi O, Honda K, Nomiya M, et al. Defining overactive bladder as hypersensitivity. Neurourol Urodyn. 2007;26(S6):904–907. doi: 10.1002/nau.20482
- Lee SR, Kim HJ, Kim A, Kim JH. Overactive bladder is not only overactive but also hypersensitive. Urology. 2010;75(5):1053–1059. doi: 10.1016/j.urology.2009.10.045
- Homma Y. Hypersensitive bladder: towards clear taxonomy surrounding interstitial cystitis. Int J Urol. 2013;20(8):742–743. doi: 10.1111/iju.12143
- Macdiarmid SA, Sand PK. Diagnosis of interstitial cystitis / painful bladder syndrome in patients with overactive bladder symptoms. Rev Urol. 2007;9(1):9–16.
- Chung MK, Butrick CW, Chung CW. The overlap of interstitial cystitis /painful bladder syndrome and overactive bladder. JSLS. 2010;14(1):83–90. doi: 10.4293/108680810X12674612014743
- Thu JHL, Vetter J, Lai HH. The severity and distribution of nonurologic pain and urogenital pain in overactive bladder are intermediate between interstitial cystitis and controls. Urology. 2019;130:59–64. doi: 10.1016/j.urology.2019.03.030
- Ates E, Ipekci T, Akin Y, et al. Impact of sympathetic dysfunction in the etiology of overactive bladder in women: A preliminary study. Neurourol Urodyn. 2016;35(1):26–28. doi: 10.1002/nau.22652
- Minaglia S, Ozel B, Bizhang R, Mishell DR Jr. Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy. Urology. 2005;66(4):702–706. doi: 10.1016/j.urology.2005.04.042
- Delaere KPJ, Debruyne FMJ, Moonen WA. The use of indomethacin in the treatment of idiopathic bladder instability. Urol Int. 1981;36(2):124–127. doi: 10.1159/000280402
- Al-Shukri SH, Kuzmin IV, Slesarevskaya MN, Ignashov YuA. Bladder hydrodistension in treating patients with interstytial cystitis / bladder pain syndrome. Urologiia. 2018;(1):26–29. doi: 10.18565/urology.2018.1.26-29 EDN: YRSGPY
- Martov AG, Muzhetskaya NG, Slyukova YuR, Salyukov RV Minimally invasive methods of treatment of interstitial cystitis / painful bladder syndrome. Urologiia. 2020(5):93–98. doi: 10.18565/urology.2020.5.93-98 EDN: NKXWXO
- Slesarevskaya MN, Kuzmin IV, Ignashov YuA. Intravesical injections of triamcynolone and bladder hydrodistension in the treatment of patients with primary bladder pain syndrome. Experimental and Clinical Urology. 2023;16(4): 164–171. doi: 10.29188/2222-8543-2023-16-4-164-171 EDN: RCSRQI
- Krivoborodov GG, Kuzmin IV, Slesarevskaya MN, et al. Botulinum toxin therapy in urology: historical aspect. Urology reports (St. Petersburg). 2024;14(2):163–174. doi: 10.17816/uroved633370 EDN: NLRSLD
补充文件
